Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Figure 6.Overexpression of KLRB1 inhibited migration and invasion of breast cancer cells. (A–D) The migration of MDA-MB-231 and HS578T cells; (E–H) The invasion of MDA-MB-231 and HS578T cells.